Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.1960
-0.0413 (-17.40%)
Oct 30, 2026, 2:28 PM EDT - Market open

LABT Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, LABT stock has an average price target of $7.50. The average 1-year stock price forecast is 3,726.53% higher than the current stock price, while the lowest is $3.00 (+1,430.61%) and the highest is $12 (+6,022.45%).

Price Target: $7.50 (+3,726.53%)
Analyst Consensus: n/a

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.00$7.50$7.50$12
Change+1430.6%+3726.5%+3726.5%+6022.4%

Analyst Ratings

There are currently no analyst ratings available for LABT.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.96
from -8.40
EPS Next Year
-1.32
from -4.96
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----
Operating Income
-8.64M-4.03M-3.77M-8.20M
Net Income
-8.28M-4.86M-3.85M-8.20M
EPS
-12.16-9.92-8.40-4.96
No. Analysts
---1

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-4.96
Avg-4.96
Low-4.96

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-